| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.089 | 0.007 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.009 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |